Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:37 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Argentina · Brazil · Denmark · France · Germany · Israel · Italy · Japan · Mexico · Puerto Rico · Spain · United States
Registry dates and results
Start: 2025-04-25. Completion: 2026-12 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug) — also listed as: LY3298176
Placebo (drug)
Where the study takes place — 146 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Santa Barbara, California, United States
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Start: 2026-05. Completion: 2029-05 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
IMSS Clínica Río Magdalena Mexico City, Mexico City, Mexico Site recruitment: Not reported
Residual Gastric Contents; Pulmonary Aspiration of Gastric Contents
Sponsor
St Vincent's Hospital Melbourne
Countries with listed sites
Australia
Registry dates and results
Start: 2025-06-20. Completion: 2027-02-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
24-hour clear liquid diet (other)
Standard fasting guidelines (other)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Melbourne Gastro Oesophageal Surgery (MGOS) Melbourne, Victoria, Australia Site recruitment: Recruiting
St Vincent's Hospital Melbourne Melbourne, Victoria, Australia Site recruitment: Recruiting
Start: 2024-02-11. Completion: 2028-09-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Evaluating the acute effect of an amino acid infusion with and without a concomitant infusion of the somatostatin analogue octreotide to eliminate endogenous production of glucagon (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Bispebjerg University Hospital Copenhagen, Denmark Site recruitment: Not reported
Start: 2020-11-01. Completion: 2027-04-30 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide (drug)
Exercise training (other)
Liraglutide + Exercise training (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Virginia Charlottesville, Virginia, United States Site recruitment: Recruiting
Start: 2024-04-24. Completion: 2026-04-02 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug) — also listed as: LY3298176
Mibavademab (drug) — also listed as: REGN4461
Tirzepatide-Placebo (drug)
Mibavademab-Placebo (drug)
Where the study takes place — 17 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Velocity Clinical Research, Gardena Gardena, California, United States Site recruitment: Not reported
Irvine Clinical Research Irvine, California, United States Site recruitment: Not reported
Velocity Clinical Research, Los Angeles Los Angeles, California, United States Site recruitment: Not reported
Velocity Clinical Research, North Hollywood North Hollywood, California, United States Site recruitment: Not reported
Velocity Clinical Research, Santa Ana Santa Ana, California, United States Site recruitment: Not reported
Velocity Clinical Research, Panorama City Van Nuys, California, United States Site recruitment: Not reported
Diablo Clinical Research, Inc. Walnut Creek, California, United States Site recruitment: Not reported
Solaris Clinical Research Meridian, Idaho, United States Site recruitment: Not reported
Tandem Clinical Research Marrero, Louisiana, United States Site recruitment: Not reported
Velocity Clinical Research - New Orleans New Orleans, Louisiana, United States Site recruitment: Not reported
Hassman Research Institute Marlton Site Marlton, New Jersey, United States Site recruitment: Not reported
Lillestol Research Fargo, North Dakota, United States Site recruitment: Not reported
CTI Clinical Research Center Cincinnati, Ohio, United States Site recruitment: Not reported
South Texas Clinical Research Corpus Christi, Texas, United States Site recruitment: Not reported
Velocity Clinical Research, Dallas Dallas, Texas, United States Site recruitment: Not reported
Juno Research Houston, Texas, United States Site recruitment: Not reported
Northwest Clinical Research Center Bellevue, Washington, United States Site recruitment: Not reported
Start: 2026-08. Completion: 2027-06 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug)
Exercise (behavioral)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Virginia Charlottesville, Virginia, United States Site recruitment: Not reported
Clinica Universidad de Navarra, Universidad de Navarra
Countries with listed sites
Spain
Registry dates and results
Start: 2024-10-21. Completion: 2026-12-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Gastric Ultrasound (diagnostic_test)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Clinica Universidad Navarra Madrid, Madrid, Spain Site recruitment: Recruiting
CAUSA Salamanca Salamanca, Spain Site recruitment: Recruiting
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Duchess of Kent Children's Hospital at Sandy Bay Hong Kong, Hong Kong SAR, China Site recruitment: Not yet recruiting
Queen Mary Hospital Hong Kong, Hong Kong SAR, China Site recruitment: Recruiting
Tung Wah Hospital Hong Kong, Hong Kong SAR, China Site recruitment: Recruiting
Start: 2026-03-09. Completion: 2030-05 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Ixekizumab (drug)
Tirzepatide (drug)
Where the study takes place — 4 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University Hospitals Birmingham NHS Foundation Trust Birmingham, England, United Kingdom Site recruitment: Not yet recruiting
University Hospitals Coventry and Warwickshire NHS Trust Coventry, England, United Kingdom Site recruitment: Not yet recruiting
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, England, United Kingdom Site recruitment: Not yet recruiting
NHS Greater Glasgow and Clyde Glasgow, Scotland, United Kingdom Site recruitment: Recruiting
Start: 2024-06-13. Completion: 2026-04-21 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
DD01 (drug)
Placebo (drug)
Where the study takes place — 12 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Summit Research Site Maitland, Florida, United States Site recruitment: Not reported
Summit Research Site Monroe, Louisiana, United States Site recruitment: Not reported
Summit Research Site West Monroe, Louisiana, United States Site recruitment: Not reported
Summit Research Site Kansas City, Missouri, United States Site recruitment: Not reported
Summit Research Site Austin, Texas, United States Site recruitment: Not reported
Summit Research Site Bellaire, Texas, United States Site recruitment: Not reported
Summit Research Site Brownsville, Texas, United States Site recruitment: Not reported
Summit Research Site Corpus Christi, Texas, United States Site recruitment: Not reported
Summit Research Site Edinburg, Texas, United States Site recruitment: Not reported
Summit Research Site Georgetown, Texas, United States Site recruitment: Not reported
Summit Research Site San Antonio, Texas, United States Site recruitment: Not reported
Summit Research Site San Antonio, Texas, United States Site recruitment: Not reported
Start: 2023-10-24. Completion: 2028-03-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Dapagliflozin 10 MG (drug) — also listed as: FARXIGA
Semaglutide, 1.0 mg/mL (drug) — also listed as: OZEMPIC
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Toronto General Hospital Toronto, Ontario, Canada Site recruitment: Recruiting
Start: 2019-03-18. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide (drug)
RFM (other)
Anti Arrhythmics (drug)
Afib Catheter Ablation (procedure)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Miami Miami, Florida, United States Site recruitment: Not reported
Start: 2016-11. Completion: 2027-06 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
liraglutide (drug) — also listed as: Saxenda
Placebo (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Beth Israel Deaconess Medical Center General Clinical Research Center Boston, Massachusetts, United States Site recruitment: Not reported
Start: 2026-04-20. Completion: 2026-11-30 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
On GLP1 plus HRT (drug)
On GLP1 Only (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
West Dermatology Research Center San Diego, California, United States Site recruitment: Not reported
Start: 2025-08-01. Completion: 2028-07-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Semaglutide administration plus dietary counselling and physical activity encouragement (drug) — also listed as: Semaglutide with dietary counselling and physical activity encouragement
Semaglutide plus a personalised and supervised program of resistance and endurance training (drug) — also listed as: Semaglutide plus personalised and supervised resistance and endurance training program
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Cardiac Research Office, Aberdeen Royal Infirmary Aberdeen, Aberdeenshire, United Kingdom Site recruitment: Recruiting
Type 2 Diabetes; Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Countries with listed sites
China
Registry dates and results
Start: 2026-04-01. Completion: 2028-08-30 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
GLP-1 Receptor Agonists (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
the First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China Site recruitment: Recruiting
Start: 2023-01-04. Completion: 2026-04-01 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
GIP(1-42) (drug)
GLP-1 (drug)
GLP-2 (drug)
Placebo (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Center for Clinical Metabolic Research, Gentofte Hospital Hellerup, Denmark Site recruitment: Not reported
Start: 2025-03-18. Completion: 2027-08 (may be estimated). No results posted in this registry response.
Products and interventions (6)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Glucagon (part C) (other)
Glucose clamp (part C) (other)
Saline (part C) (other)
Glucagon (part D) (other)
Glucose clamp (part D) (other)
Saline (part D) (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark Copenhagen, Denmark Site recruitment: Not reported
Overweight or Obesity; Type 2 Diabetes; Weight Loss Maintenance
Sponsor
Huazhong University of Science and Technology
Countries with listed sites
China
Registry dates and results
Start: 2026-04-30. Completion: 2028-09-30 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
AI assisted multi-domain lifestyle intervention (behavioral)
Tirzepatide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China Site recruitment: Not reported
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.